Venn Life Sciences Holdings PLC Half year end update (5675L)
July 20 2017 - 1:00AM
UK Regulatory
TIDMVENN
RNS Number : 5675L
Venn Life Sciences Holdings PLC
20 July 2017
Venn Life Sciences Holdings Plc
("Venn" or the "Company" or the "Group")
Half year end update
Venn Life Sciences (AIM: VENN), a growing Contract Research
Organisation providing drug development, clinical trial management
and resourcing solutions to pharmaceutical, biotechnology and
medical device clients, provides the following update for the six
months ended 30 June 2017.
The new financial year started well with contract wins of
EUR5.7m secured in January and February, as previously announced.
Overall, the Company has achieved total revenues of EUR9.1m (H2
2016 EUR8.84m) for the first six months of the year. Our client and
revenue mix remains well balanced with strong rates of repeat
business and we have successfully delivered initial cross sales
between the early and late phase client bases. We have a strong
proposals book which coupled with this solid first half performance
provides confidence around full year revenue expectations. We
finished the first half year with a cash position of EUR2.9m
(EUR1.75m as at 30 June 2016).
Enquiries:
Venn Life Sciences Holdings
Plc
Allan Wood - Non executive Tel: +44 7785 325898
Chairman
Tony Richardson, Chief Executive Tel: +353 154 99 341
Officer
Davy (Nominated Adviser, ESM
Adviser and Joint Broker)
Fergal Meegan / Matthew DeVere Tel: +353 1 679 6363
White (Corporate Finance)
Hybridan LLP (Co-Broker)
Claire Louise Noyce Tel: +44(0) 20 3764
2341
Walbrook PR Ltd Tel: +44(0)20 7933 8787 or venn@walbrookpr.com
Paul McManus Mob: +44(0) 7980 541
893
Lianne Cawthorne Mob: +44(0) 7584 391
303
About Venn Life Sciences:
Venn Life Sciences is a Clinical Research Organisation providing
clinical trial management and resourcing solutions to
pharmaceutical, biotechnology and medical device organisations.
With dedicated operations in France, Germany, the Netherlands, the
UK, Ireland and Europe wide representation - Venn specialises in
rapid deployment and management of multisite projects.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTGGUGWMUPMPUB
(END) Dow Jones Newswires
July 20, 2017 02:00 ET (06:00 GMT)
Hvivo (LSE:HVO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From Jul 2023 to Jul 2024